F50.0 F50.1
Conditions
Interventions
Group 1: In the acute phase, patients will receive inpatient treatment to avoid somatic complications over 4 – 8 weeks with 24-hrs hospital stay.
Treatment components: The treatment follows a proven
Sponsors
Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters des Universitätsklinikums RWTH Aachen
Eligibility
Sex/Gender
All
Age
12 Years to 18 Years
Inclusion criteria
Inclusion criteria: - Presence of Anorexia Nervosa or atypical AN considering DSM-5 criteria - first or second hospital admission on a child and adolescent psychiatric ward due to the eating disorder - Written informed consent by the patient and the parents - Patient’s home within a 60 minute drive from the hospital
Exclusion criteria
Exclusion criteria: - Patients who additionally suffer from a somatic brain disorder, psychotic disorder, bipolar disorder, substance abuse disorder, serious self-injury, Borderline personality disorder, or serious other medical conditions. - Insufficient proficiency of the German language of either patient or parents - Cognitive abilites in the range of learning disability (< 85) as evaluated with standard diagnostic test procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in BMI at hospital admission and at end of home Treatment (approx. 12-24 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in BMI at hospital admission and at follow-up (52 weeks after hospital admission). Proportion of completed (by protocol) vs. discontinued Home treatment cases. Frequency of rehospitalizations across the observation period of 52 weeks after discharge from hospital; questionnaires and structured interview data (for an overview see below) of the patients regarding eating disorder symptoms, psychiatric comorbidity, weight restoration, motivation for therapy, general psychosocial functioning, Morgan-Russell-criteria to monitor the recovery process and hormonal levels (blood withdrawal); regarding the parents inquiry of parental burden, caretaker’s abilities in supporting the patient as well as the impact of the eating disorder on the familial dealing with the disorder; in patients and their parents inquiry of treatment satisfaction and subjective patient-therapist-relationship at beginning of home treatment, end of home treatment and 52 weeks after initial hospital admission. Measures T1 (hospital admission): Patients: Eating Disorder Examination German version (Interview) (EDE) Mini international neuropsychiatric interview for children and adolescents (MINI-KID) Eating Disorder Inventory (EDI II) Beck‘s Depression Inventory (BDI II) Anorexia Nervosa Stages of Change Questionnaire (ANSOCQ) Kidscreen (Kidscreen children 27) Brief Symptom Inventory (BSI youths). Parents: Beck‘s Depression Inventory (BDI II) Brief Symptom Inventory (BSI) WHO Quality of Life (WHOQOL-BREF) Eating Disorder Symptom Impact Scale (EDSIS) Scale to Measure Caregiver Skills in Eating Disorders (CASK) Accomodation and Enabling Scale for Eating Disorders (AESED) Kidscreen parental report (Kidscreen parents 27). Psychologist/Psychiatrist: Morgan-Russell Outcome Assessment Schedule(MROAS) Children’s Global Assessment Scale (CGAS / GAF). Measures T2 (beginning of home treatment): Patients: Eating Disorder Inventory (EDI II) Becks Depression Inventory (BDI II) Anorexia Nervosa Stages of Chan | — |
Countries
Germany
Contacts
Public ContactBrigitte Dahmen
Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters des Universitätsklinikums RWTH Aachen
Outcome results
None listed